Status:

UNKNOWN

Tissue Collection Study for Patients With Non-Small Cell Lung Cancer With Resectable Disease

Lead Sponsor:

Precision Therapeutics

Conditions:

Non-Small Cell Lung Cancer

Eligibility:

All Genders

18+ years

Brief Summary

A 15-gene lung signature was created to identify predictive and prognostic biomarkers for Non-Small Cell Lung Cancer (NSCLC) patients. The 15-gene signature was validated using a microarray platform w...

Detailed Description

Patients with early stage NSCLC will be consented prior to surgery so that any excess tissue collected during surgery can be collected in one of the three tissue formats (Fresh Frozen, FFPE, RNAlater)...

Eligibility Criteria

Inclusion

  • New diagnosis of stage I or II Non-Small Cell Lung Cancer (NSCLC)
  • Must have resectable disease and complete surgical resection planned
  • Histologically or cytologically confirmed adenocarcinoma, squamous or large cell carcinoma NSCLC
  • No prior chemotherapy, biologic/molecular targeted therapy or radiation therapy for this cancer
  • Tumor specimen samples must be collected within 1 hour of surgery
  • Patient must be at least 18 years of age
  • Patient must sign and date an approved study consent form

Exclusion

  • Patients with psychiatric or addictive disorders that would preclude obtaining study consent
  • Informed consent obtained the same day as surgery
  • Absence of histological diagnosis of lung cancer
  • Known infectious disease
  • History of chemotherapy, biologic/molecular targeted therapy or radiation therapy for this cancer or any prior cancer or any other non-cancer diseases or illnesses, i.e. rheumatoid arthritis

Key Trial Info

Start Date :

October 1 2011

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

Estimated Enrollment :

450 Patients enrolled

Trial Details

Trial ID

NCT01450553

Start Date

October 1 2011

Last Update

January 11 2012

Active Locations (7)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 2 (7 locations)

1

Cardio-Thoracic Surgeons, P. C.

Birmingham, Alabama, United States

2

University of Alabama at Birmingham

Birmingham, Alabama, United States

3

Martin Memorial Treasure Coast Surgeons

Stuart, Florida, United States

4

Baptist Hospital East

Louisville, Kentucky, United States

Tissue Collection Study for Patients With Non-Small Cell Lung Cancer With Resectable Disease | DecenTrialz